Inclusive of all taxes
HPNORIN 40 - Enoxaparin Sodium Injection BP 40mg/0.4ml is a critical pharmaceutical intervention in cardiac care, designed to prevent and treat thromboembolic conditions through its formulation of low-molecular-weight heparin (LMWH). Each pre-filled syringe delivers a precise dosage of 40mg Enoxaparin Sodium in a convenient 0.4ml volume. It functions by effectively inhibiting clotting factors, specifically Factor Xa and thrombin, thereby reducing the risk of blood clot formation. HPNORIN 40 is indicated for preventing deep vein thrombosis (DVT), managing pulmonary embolism (PE), and addressing other clot-related complications, particularly beneficial for patients undergoing significant orthopedic or abdominal surgeries, and those with reduced mobility. In acute coronary syndrome scenarios, such as unstable angina and myocardial infarction, HPNORIN 40 aids in enhancing blood flow to the heart. Administered subcutaneously under medical supervision, it ensures accurate dosing and hassle-free usage. To maintain its integrity, the product must be stored at a controlled room temperature of 15°C to 25°C (59°F to 77°F) and protected from light or freezing. Always consult a healthcare professional for optimal results and guidance on dosage and potential adverse reactions.
Key Features
| Features | Description |
|---|---|
| Formulation | Low-Molecular-Weight Heparin (LMWH) |
| Dosage | 40mg/0.4ml per pre-filled syringe |
| Primary Indication | Prevention and treatment of DVT and PE |
| Additional Use | Management of acute coronary syndromes |
| Administration | Subcutaneously under medical supervision |
| Storage Conditions | Control at 15°C to 25°C, protect from light |
| Expiry and Safety | Must be kept out of reach of children and used only as prescribed |
| Attributes | Description |
|---|---|
| Product Name | HPNORIN 40 - Enoxaparin Sodium Injection |
| Injection Volume | 0.4ml |
| Active Ingredient | Enoxaparin Sodium |
| Concentration | 40mg |
| Packaging | Pre-filled syringe |
| Use Case | Management of thromboembolic conditions |
| Route of Administration | Subcutaneous |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
HPNORIN 40 is primarily indicated for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and the management of acute coronary syndromes such as unstable angina.
HPNORIN 40 should be stored at a controlled room temperature of 15°C to 25°C (59°F to 77°F) and protected from light. It must not be frozen.
HPNORIN 40 should be administered subcutaneously by a healthcare provider under proper medical supervision to ensure accuracy and safety.
Yes, HPNORIN 40 must be used under medical supervision, and a prescription is necessary to ensure it is administered safely and effectively.
While HPNORIN 40 may be used in outpatient settings, it is essential that its administration is guided by a healthcare professional, especially for patients with specific health conditions or undergoing certain surgeries.
Brand: hpnorin 40
Country Of Origin: India
Product Information: HPNORIN 40 - Enoxaparin Sodium Injection BP 40mg/0.4ml
HPNORIN 40 is a low-molecular-weight heparin (LMWH) used in cardiac care to prevent and treat thromboembolic conditions. Each pre-filled syringe contains 40mg/0.4ml of Enoxaparin Sodium, a highly effective anticoagulant that works by inhibiting clotting factors, particularly Factor Xa and thrombin, reducing the risk of blood clot formation.
Indicated for the prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and other clot-related complications, HPNORIN 40 is particularly beneficial for patients undergoing major orthopedic or abdominal surgeries and those with restricted mobility. Additionally, it plays a vital role in managing acute coronary syndromes, such as unstable angina and myocardial infarction, by improving blood flow to the heart.
With its convenient pre-filled syringe format, HPNORIN 40 ensures accurate dosing and ease of administration. It must be used under medical supervision, considering individual patient profiles and coagulation parameters.
Enoxaparin Sodium Injection BP 40mg/0.4ml - HPNORIN 40
Usage:
HPNORIN 40 is a low-molecular-weight heparin (LMWH) indicated for the prevention and treatment of blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in patients undergoing certain types of surgeries or at risk for clotting due to immobility. Additionally, it plays a role in managing acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The injection is administered subcutaneously as directed by a healthcare provider.
Storage:
Store HPNORIN 40 at a controlled room temperature of 15°C to 25°C (59°F to 77°F). Protect the product from light and do not freeze. Ensure the syringe is kept out of reach of children and used only under medical supervision.
For optimal results, follow the prescribed dosage schedule and consult a healthcare professional for any concerns or adverse reactions.
Inclusive of all taxes
You Save: 0
